Furthermore, these findings imply that the effects of TO treatment were indeed attributed to the inhibition of Cx43‐based intercellular GJs, consequently augmenting the vulnerability of glioblastoma cells to chemotherapy. Here, GJA1 is linked to glioblastoma.